Literature DB >> 33694288

Translational remodeling by RNA-binding proteins and noncoding RNAs.

J J David Ho1,2, Jeffrey H S Man3,4,5, Jonathan H Schatz1,2, Philip A Marsden3,4.   

Abstract

Responsible for generating the proteome that controls phenotype, translation is the ultimate convergence point for myriad upstream signals that influence gene expression. System-wide adaptive translational reprogramming has recently emerged as a pillar of cellular adaptation. As classic regulators of mRNA stability and translation efficiency, foundational studies established the concept of collaboration and competition between RNA-binding proteins (RBPs) and noncoding RNAs (ncRNAs) on individual mRNAs. Fresh conceptual innovations now highlight stress-activated, evolutionarily conserved RBP networks and ncRNAs that increase the translation efficiency of populations of transcripts encoding proteins that participate in a common cellular process. The discovery of post-transcriptional functions for long noncoding RNAs (lncRNAs) was particularly intriguing given their cell-type-specificity and historical definition as nuclear-functioning epigenetic regulators. The convergence of RBPs, lncRNAs, and microRNAs on functionally related mRNAs to enable adaptive protein synthesis is a newer biological paradigm that highlights their role as "translatome (protein output) remodelers" and reinvigorates the paradigm of "RNA operons." Together, these concepts modernize our understanding of cellular stress adaptation and strategies for therapeutic development. This article is categorized under: RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications Translation > Translation Regulation Regulatory RNAs/RNAi/Riboswitches > Regulatory RNAs.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  cancer; endothelial; hypoxia; proteomics; translation

Mesh:

Substances:

Year:  2021        PMID: 33694288     DOI: 10.1002/wrna.1647

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  7 in total

1.  LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13.

Authors:  Huixin Zhou; Xiaolu Huang; Wenjing Shi; Shihao Xu; Jie Chen; Kate Huang; Yumin Wang
Journal:  Cell Cycle       Date:  2022-03-17       Impact factor: 5.173

Review 2.  The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis.

Authors:  Kim-Alicia Palzer; Vanessa Bolduan; Rudolf Käfer; Hartmut Kleinert; Matthias Bros; Andrea Pautz
Journal:  Cells       Date:  2022-04-28       Impact factor: 7.666

Review 3.  Research progress of DLX6-AS1 in human cancers.

Authors:  Yalan Luo; Peng Ge; Mengfei Wang; Haiyang Chen; Jiayue Liu; Tianfu Wei; Yuankuan Jiang; Jialin Qu; Hailong Chen
Journal:  Hum Cell       Date:  2021-09-11       Impact factor: 4.374

4.  Reimagining the Power of Nucleic Acids as Therapeutic and Diagnostic Agents.

Authors:  Anthony Berdis
Journal:  Biomolecules       Date:  2021-11-17

5.  Rbfox1 is required for myofibril development and maintaining fiber type-specific isoform expression in Drosophila muscles.

Authors:  Elena Nikonova; Amartya Mukherjee; Ketaki Kamble; Christiane Barz; Upendra Nongthomba; Maria L Spletter
Journal:  Life Sci Alliance       Date:  2022-01-07

6.  Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.

Authors:  Chengyin Weng; Lina Wang; Guolong Liu; Mingmei Guan; Lin Lu
Journal:  Front Oncol       Date:  2021-11-18       Impact factor: 6.244

7.  A Single Transcript Knockdown-Replacement Strategy Employing 5' UTR Secondary Structures to Precisely Titrate Rescue Protein Translation.

Authors:  Matthew M Millette; Elizabeth D Holland; Tanner J Tenpas; Erik W Dent
Journal:  Front Genome Ed       Date:  2022-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.